Results 1 to 10 of about 442,345 (289)
Evaluation of prostate volume in mpMRI: comparison of the recommendations of PI-RADS v2 and PI-RADS v2.1 [PDF]
Diagnostic and Interventional Radiology, 2021 PURPOSEWe aimed to evaluate the prostate volumes calculated as recommended in the PI-RADS v2 and PI-RADS v2.1 guidelines, intraobserver and interobserver variability, and the agreement between the two measurement methods.METHODSProstate mpMRI ...
Elif Gündoğdu, Emre Emekli
doaj +7 more sources
Urology Research and Practice, 2021 Biparametric magnetic resonance imaging (bpMRI) of the prostate has emerged as an alternative to multiparametric MRI (mpMRI) for the detection of clinically significant prostate cancer (csPCa).
Michele Scialpi +7 more
doaj +6 more sources
Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart [PDF]
TomographyObjectives: This study aimed to investigate the consistency of lesion identification by Prostate Imaging Reporting and Data System (PI-RADS) and the related clinical and histological characteristics in a high-volume tertiary care center.
Justine Schoch +7 more
doaj +3 more sources
Current Oncology, 2021 Purpose: To evaluate the diagnostic performance of PI-RADS v2, proposed adjustments to PI-RADS v2 (PA PI-RADS v2) and biparametric magnetic resonance imaging (MRI) for prostate cancer detection.
Guan-Hui Cai +5 more
doaj +2 more sources
The evolving PI-RADS paradigm. [PDF]
Cancer ImagingProstate MRI is central to the diagnostic pathway for prostate cancer (PCa), reducing unnecessary biopsies, improving the detection of clinically significant disease (csPCa), and limiting overdiagnosis of indolent tumours. The Prostate Imaging Reporting and Data System (PIRADS) version 2.1 is the current international standard for MRI data acquisition ...
Ponsiglione A, Schoots IG, Padhani AR.
europepmc +5 more sources
Risk stratification for repeat prostate biopsy: PI-RADS 3 lesions and the differential role of PSA density [PDF]
Prostate InternationalPurpose: PI-RADS 3 lesions represent a diagnostic challenge in repeat prostate biopsy. We investigated whether PI-RADS 3 independently predicts negative biopsy outcomes and how PSA density (PSAD) modifies cancer detection across PI-RADS categories ...
Jungkeun Song +13 more
doaj +2 more sources
Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision [PDF]
Insights into ImagingObjectives The aim of this study was to develop and validate an MRI radiomics-based predictive model to discriminate significant prostate cancer (sPCa), compare it with PI-RADS, and determine whether incorporating PI-RADS and other clinical variables ...
Andreu Antolin +16 more
doaj +2 more sources
PI-RADS v2: Current standing and future outlook [PDF]
Urology Research and Practice, 2019 The Prostate Imaging-Reporting and Data System (PI-RADS) was created in 2012 to establish standardization in prostate multiparametric magnetic resonance imaging (mpMRI) acquisition, interpretation, and reporting. In hopes of improving upon some of the PI-
Clayton P. Smith, Barış Türkbey
doaj +3 more sources
Validation of new TRUS biopsy techniques for PI-RADS 4 or 5 [PDF]
Precision and Future Medicine, 2020 Purpose Recently, new magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) techniques and imaging features of Prostate Imaging and Report and Data System (PI-RADS) 4 or 5 have been reported. The aim of this study was to validate the outcomes of
Taein An, Byung Kwan Park
doaj +1 more source
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
The Egyptian Journal of Radiology and Nuclear Medicine, 2021 Background The study aimed to compare the diagnostic performance of T2-weighted imaging (T2WI) score 3 transition zone (TZ) lesions between Prostate Imaging and Reporting Data System (PI-RADS) v2.1 and modified PI-RADS v2.1-B. Results Among TZ lesions (n
Jihae An +6 more
doaj +1 more source